Papillomavirus truncated L1 protein and fusion protein constructs
US7182947B2 · kind B2 · utility
3Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2003 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Feb 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.